SI2262525T1 - Apoaekuorin vsebujoči sestavki in postopki njihove uporabe - Google Patents
Apoaekuorin vsebujoči sestavki in postopki njihove uporabeInfo
- Publication number
- SI2262525T1 SI2262525T1 SI200930489T SI200930489T SI2262525T1 SI 2262525 T1 SI2262525 T1 SI 2262525T1 SI 200930489 T SI200930489 T SI 200930489T SI 200930489 T SI200930489 T SI 200930489T SI 2262525 T1 SI2262525 T1 SI 2262525T1
- Authority
- SI
- Slovenia
- Prior art keywords
- apoaequorin
- methods
- same
- containing compositions
- compositions
- Prior art date
Links
- 108010041089 apoaequorin Proteins 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3544308P | 2008-03-11 | 2008-03-11 | |
| PCT/US2009/036767 WO2009114597A1 (en) | 2008-03-11 | 2009-03-11 | Apoaequorin-containing compositions and methods of using same |
| EP09720761A EP2262525B1 (en) | 2008-03-11 | 2009-03-11 | Apoaequorin-containing compositions and methods of using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2262525T1 true SI2262525T1 (sl) | 2013-03-29 |
Family
ID=40627496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200930489T SI2262525T1 (sl) | 2008-03-11 | 2009-03-11 | Apoaekuorin vsebujoči sestavki in postopki njihove uporabe |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8796213B2 (sl) |
| EP (1) | EP2262525B1 (sl) |
| JP (1) | JP5508294B2 (sl) |
| KR (1) | KR101643662B1 (sl) |
| CN (2) | CN101969979A (sl) |
| AU (1) | AU2009223010B2 (sl) |
| BR (1) | BRPI0909435A2 (sl) |
| CA (1) | CA2717322C (sl) |
| CY (1) | CY1114366T1 (sl) |
| DK (1) | DK2262525T3 (sl) |
| ES (1) | ES2401754T3 (sl) |
| HR (1) | HRP20130205T1 (sl) |
| IL (1) | IL207827A (sl) |
| MX (1) | MX2010009753A (sl) |
| NZ (1) | NZ588437A (sl) |
| PL (1) | PL2262525T3 (sl) |
| PT (1) | PT2262525E (sl) |
| SI (1) | SI2262525T1 (sl) |
| WO (1) | WO2009114597A1 (sl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2643392T3 (es) * | 2011-11-15 | 2017-11-22 | Quincy Bioscience Llc | Apoaecuorina para reducir lesiones neuronales debidas a isquemia |
| KR102195761B1 (ko) | 2012-09-27 | 2020-12-28 | 퀸시 바이오사이언스 엘엘씨 | 아포에쿼린-함유 조성물을 기반으로 하는 다발성 경화증의 증상을 완화시키는 방법 |
| MA40959A (fr) * | 2014-11-11 | 2017-09-19 | Quincy Bioscience Llc | Compositions contenant de l'apoaéquorine et leurs procédés d'utilisation pour traiter l'inflammation neuronale |
| PL3515212T3 (pl) * | 2016-09-23 | 2024-10-14 | Quincy Bioscience Llc | Kompozycje zawierające apoekworynę i witaminę d oraz sposoby ich stosowania |
| EP3927171A4 (en) | 2019-02-22 | 2022-11-30 | Aquero Canada Ltd. | FORTIFIED MILK COMPOSITIONS AND THEIR PROCESS OF MANUFACTURE |
| BR112022016081A2 (pt) * | 2020-02-24 | 2022-10-04 | Quincy Bioscience Llc | Composições contendo apoaequorina e curcumina e métodos |
| CN116157114A (zh) * | 2020-08-20 | 2023-05-23 | 昆西生物科学有限公司 | 含脱辅基水母蛋白的泡腾制剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6447379A (en) * | 1987-08-19 | 1989-02-21 | Chisso Corp | Preparation of calcium-dependent oxygenation enzyme |
| US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
| CN1324045C (zh) * | 2004-09-22 | 2007-07-04 | 中国科学院海洋研究所 | 从水母中分离的具有抗氧化活性的蛋白及其应用 |
-
2009
- 2009-03-11 DK DK09720761.7T patent/DK2262525T3/da active
- 2009-03-11 PT PT97207617T patent/PT2262525E/pt unknown
- 2009-03-11 CN CN200980108891XA patent/CN101969979A/zh active Pending
- 2009-03-11 MX MX2010009753A patent/MX2010009753A/es active IP Right Grant
- 2009-03-11 WO PCT/US2009/036767 patent/WO2009114597A1/en not_active Ceased
- 2009-03-11 SI SI200930489T patent/SI2262525T1/sl unknown
- 2009-03-11 US US12/672,463 patent/US8796213B2/en active Active
- 2009-03-11 PL PL09720761T patent/PL2262525T3/pl unknown
- 2009-03-11 AU AU2009223010A patent/AU2009223010B2/en active Active
- 2009-03-11 EP EP09720761A patent/EP2262525B1/en active Active
- 2009-03-11 ES ES09720761T patent/ES2401754T3/es active Active
- 2009-03-11 BR BRPI0909435A patent/BRPI0909435A2/pt not_active Application Discontinuation
- 2009-03-11 HR HRP20130205AT patent/HRP20130205T1/hr unknown
- 2009-03-11 CA CA2717322A patent/CA2717322C/en active Active
- 2009-03-11 CN CN201710007032.8A patent/CN106692945A/zh active Pending
- 2009-03-11 NZ NZ588437A patent/NZ588437A/en unknown
- 2009-03-11 JP JP2010550832A patent/JP5508294B2/ja active Active
- 2009-03-11 KR KR1020107022674A patent/KR101643662B1/ko active Active
-
2010
- 2010-08-26 IL IL207827A patent/IL207827A/en active IP Right Grant
-
2013
- 2013-02-13 CY CY20131100128T patent/CY1114366T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20130205T1 (hr) | 2013-04-30 |
| IL207827A (en) | 2013-08-29 |
| IL207827A0 (en) | 2010-12-30 |
| CA2717322C (en) | 2017-07-11 |
| NZ588437A (en) | 2012-07-27 |
| BRPI0909435A2 (pt) | 2017-06-13 |
| CY1114366T1 (el) | 2016-08-31 |
| EP2262525B1 (en) | 2012-12-26 |
| CN106692945A (zh) | 2017-05-24 |
| KR20100136494A (ko) | 2010-12-28 |
| ES2401754T3 (es) | 2013-04-24 |
| CA2717322A1 (en) | 2009-09-17 |
| EP2262525A1 (en) | 2010-12-22 |
| AU2009223010A1 (en) | 2009-09-17 |
| JP5508294B2 (ja) | 2014-05-28 |
| PL2262525T3 (pl) | 2013-04-30 |
| CN101969979A (zh) | 2011-02-09 |
| AU2009223010B2 (en) | 2014-01-09 |
| KR101643662B1 (ko) | 2016-07-29 |
| US8796213B2 (en) | 2014-08-05 |
| MX2010009753A (es) | 2010-09-30 |
| JP2011513496A (ja) | 2011-04-28 |
| PT2262525E (pt) | 2013-01-28 |
| US20110124562A1 (en) | 2011-05-26 |
| DK2262525T3 (da) | 2013-02-11 |
| WO2009114597A1 (en) | 2009-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2334185A4 (en) | COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL | |
| EG27167A (en) | Microemulsifiers and methods of making and using same | |
| IL210153A0 (en) | Nutrigenomics methods and compositions | |
| SI3812360T1 (sl) | Monoklorotrifluoropropenske spojine in sestavki ter postopki, ki jih uporabljajo | |
| IL208858A0 (en) | Lipid-containing compositions and methods of use thereof | |
| IL212822A0 (en) | Anti-cxcr1 compositions and methods | |
| HRP20160902T1 (hr) | Pripravci i postupci uporabe forbolskih estera | |
| EP2231665A4 (en) | NEW COMPOSITIONS AND METHODS OF USE | |
| GB0819530D0 (en) | Methods and compositions | |
| IL210559A0 (en) | Novel compositions and methods | |
| SG10201505149WA (en) | Novel compositions and methods | |
| IL201364A0 (en) | Gas-effusing compositions and methods of making and using same | |
| GB0817585D0 (en) | Novel compositions and methods | |
| GB0812890D0 (en) | Compositions and methods of making compositions | |
| ZA201102207B (en) | Cinnamandehyde-allicin compositions and their method of use | |
| IL207827A0 (en) | Apoaequorin-containing compositions and methods of using same | |
| ZA201100114B (en) | Nutritive compositions and methods of using same | |
| EP2381950A4 (en) | COMPOSITIONS AND METHOD FOR THEIR USE | |
| GB0811250D0 (en) | Methods and compositions | |
| GB0816534D0 (en) | Compositions and methods | |
| GB0811152D0 (en) | Methods and compositions | |
| GB0818399D0 (en) | Methods and compositions | |
| GB0803464D0 (en) | Methods and compositions | |
| GB0820804D0 (en) | Perinropril composition and method of use thereof |